NBIX earnings call for the period ending March 31, 2021.
News & Analysis: Neurocrine Biosciences
The stock is being added to a mid-cap index.
NBIX earnings call for the period ending December 31, 2020.
NBIX earnings call for the period ending September 30, 2020.
The much-anticipated launch of Ongentys has arrived.
Three years after treatment with NBIb-1817, Parkinson's disease patients still are still showing improvements.
NBIX earnings call for the period ending June 30, 2020.
The biotech blew past Wall Street estimates with soaring sales of Ingrezza.
The biopharmaceutical company has seen shares rise 44.5% in less than two months.
The company's Ingrezza continues to power its revenue and profitability growth.